| Literature DB >> 25448363 |
Figueroa-Valverde Lauro1, Díaz-Cedillo Francisco2, García-Cervera Elodia3, Pool-Gómez Eduardo3, López-Ramos Maria3, Rosas-Nexticapa Marcela4, Hau-Heredia Lenin3, Sarabia-Alcocer Bety5.
Abstract
In this study two androgen derivatives were synthesized using several strategies; the first stage an aza-steroid derivative (3) was developed by the reaction of a testosterone derivative (1) with thiourea (2) in presence of hydrogen chloride. The second step, involves the synthesis of an amino-steroid derivative (4) by the reaction of 1 with 2 using boric acid as catalyst. The third stage was achieved by the preparation of an aminoaza-androgen derivative (6) by the reaction of 3 with ethylenediamine using boric acid as catalyst. In addition, the compound 6 was made reacting with dihydrotestosterone to form a new androgen derivative (7) in presence of boric acid. The following step was achieved by the reaction of 7 with chloroacetyl chloride to synthesize an azetidinone-androgen derivative (8) using triethylamine as catalyst. Additionally, a thiourea-androgen derivative (9) was synthetized by the reaction of 4 with dihydrotestosterone using boric acid as catalyst. Finally, the compound 9 was made reacting with chloroacetyl chloride in presence of triethylamine to synthesize a new azetidinone-androgen derivative (10). On the other hand, antibacterial activity of compounds synthesized was evaluated on Gram negative (Escherichia coli and Vibrio cholerae) and Gram positive (Staphylococos aureus) bacteria. The results indicate that only the compound 3 and 8 decrease the growth bacterial of E. coli and V. cholerae. Nevertheless, growth bacterial of S. aureus was not inhibited by these compounds. These data indicate that antibacterial activity exerted by the compounds 3 and 8 depend of their structure chemical in comparison with the controls and other androgen derivatives that are involved in this study.Entities:
Keywords: Androgen derivative; Bacteria; Boric acid; Testosterone
Mesh:
Substances:
Year: 2014 PMID: 25448363 DOI: 10.1016/j.steroids.2014.09.003
Source DB: PubMed Journal: Steroids ISSN: 0039-128X Impact factor: 2.668